name,category,termsB-cell CLL/lymphoma 7A,INTERPRO[450006210$IPR006804:BCL7, N-terminal]
B-cell CLL/lymphoma 7A,OMIM_DISEASE[520000500$B-cell non-Hodgkin lymphoma, high-grade]
B-cell CLL/lymphoma 7A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
B-cell CLL/lymphoma 7A,UP_SEQ_FEATURE[850007046$chain:B-cell CLL/lymphoma 7 protein family member A, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
DiGeorge syndrome critical region gene 8,INTERPRO[450001016$IPR001159:Double-stranded RNA binding, 450001055$IPR001202:WW/Rsp5/WWP, 450013172$IPR014720:Double-stranded RNA-binding-like]
DiGeorge syndrome critical region gene 8,SMART[760000326$SM00358:DSRM, 760000401$SM00456:WW]
DiGeorge syndrome critical region gene 8,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000652$heme, 790000802$iron, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
DiGeorge syndrome critical region gene 8,UP_SEQ_FEATURE[850031670$chain:Microprocessor complex subunit DGCR8, 850103546$domain:DRBM 1, 850103547$domain:DRBM 2, 850105731$domain:WW, 850105852$helix, 850106026$metal ion-binding site:Iron (heme axial ligand), 850106258$modified residue, 850106259$mutagenesis site, 850113584$region of interest:Necessary for heme-binding and pri-miRNA processing, 850113620$region of interest:Necessary for interaction with NCL, 850113644$region of interest:Necessary for interaction with RNASEN, 850113678$region of interest:Necessary for nuclear localization and retention, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
RUN and FYVE domain containing 3,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
RUN and FYVE domain containing 3,INTERPRO[450003532$IPR004012:RUN]
RUN and FYVE domain containing 3,SMART[760000527$SM00593:RUN]
RUN and FYVE domain containing 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001016$neurogenesis, 790001162$phosphoprotein]
RUN and FYVE domain containing 3,UP_SEQ_FEATURE[850047544$chain:Protein RUFY3, 850105223$domain:RUN, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
SH2 domain containing 1B,INTERPRO[450000852$IPR000980:SH2 motif]
SH2 domain containing 1B,KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity]
SH2 domain containing 1B,PIR_SUPERFAMILY[630029284$PIRSF037711:SH2 domain protein 1B]
SH2 domain containing 1B,SMART[760000224$SM00252:SH2]
SH2 domain containing 1B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001397$SH2 domain]
SH2 domain containing 1B,UP_SEQ_FEATURE[850060510$chain:SH2 domain-containing protein 1B, 850105346$domain:SH2, 850117295$sequence variant, 850118574$splice variant]
bone morphogenetic protein 8b,INTERPRO[450000974$IPR001111:Transforming growth factor beta (TGFb), N-terminal, 450001626$IPR001839:Transforming growth factor beta, 450002138$IPR002405:Inhibin, alpha subunit, 450014053$IPR015615:Transforming growth factor-beta-related, 450016259$IPR017948:Transforming growth factor beta, conserved site]
bone morphogenetic protein 8b,KEGG_PATHWAY[470038849$hsa04340:Hedgehog signaling pathway, 470038850$hsa04350:TGF-beta signaling pathway]
bone morphogenetic protein 8b,SMART[760000177$SM00204:TGFB]
bone morphogenetic protein 8b,SP_PIR_KEYWORDS[790000307$Chondrogenesis, 790000356$complete proteome, 790000402$cytokine, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000632$growth factor, 790001083$osteogenesis, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
bone morphogenetic protein 8b,UP_SEQ_FEATURE[850008230$chain:Bone morphogenetic protein 8B, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
carbonyl reductase 3,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450014426$IPR016040:NAD(P)-binding domain]
carbonyl reductase 3,KEGG_PATHWAY[470038780$hsa00590:Arachidonic acid metabolism]
carbonyl reductase 3,PIR_SUPERFAMILY[630000106$PIRSF000092:short-chain dehydrogenase]
carbonyl reductase 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism]
carbonyl reductase 3,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000461$binding site:NADP, 850000465$binding site:NADP; via carbonyl oxygen, 850000555$binding site:Substrate, 850009476$chain:Carbonyl reductase [NADPH] 3, 850105852$helix, 850106307$nucleotide phosphate-binding region:NADP, 850117295$sequence variant, 850118575$strand, 850118624$turn]
catenin, beta interacting protein 1,INTERPRO[450008532$IPR009428:Beta-catenin-interacting ICAT]
catenin, beta interacting protein 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway]
catenin, beta interacting protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001642$wnt signaling pathway]
catenin, beta interacting protein 1,UP_SEQ_FEATURE[850007601$chain:Beta-catenin-interacting protein 1, 850105852$helix]
collagen, type VI, alpha 3,INTERPRO[450001802$IPR002035:von Willebrand factor, type A, 450001971$IPR002223:Proteinase inhibitor I2, Kunitz metazoa, 450003484$IPR003961:Fibronectin, type III, 450007490$IPR008160:Collagen triple helix repeat, 450008173$IPR008957:Fibronectin, type III-like fold]
collagen, type VI, alpha 3,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction]
collagen, type VI, alpha 3,OMIM_DISEASE[520000561$Bethlem myopathy, 520004976$Ullrich congenital muscular dystrophy]
collagen, type VI, alpha 3,PIR_SUPERFAMILY[630002388$PIRSF002259:collagen VI]
collagen, type VI, alpha 3,SMART[760000051$SM00060:FN3, 760000113$SM00131:KU, 760000296$SM00327:VWA]
collagen, type VI, alpha 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000189$blocked amino end, 790000256$cell adhesion, 790000257$cell binding, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001253$protease inhibitor, 790001289$pyroglutamic acid, 790001291$Pyrrolidone carboxylic acid, 790001304$repeat, 790001363$Secreted, 790001385$Serine protease inhibitor, 790001405$signal, 790001565$trimer, 790001568$triple helix]
collagen, type VI, alpha 3,UP_SEQ_FEATURE[850012213$chain:Collagen alpha-3(VI) chain, 850102378$compositionally biased region:Ala-rich, 850102605$compositionally biased region:Thr-rich, 850102883$disulfide bond, 850103140$domain:BPTI/Kunitz inhibitor, 850103390$domain:Collagen-like 1, 850103399$domain:Collagen-like 2, 850103400$domain:Collagen-like 3, 850103401$domain:Collagen-like 4, 850103402$domain:Collagen-like 5, 850103799$domain:Fibronectin type-III, 850105628$domain:VWFA 1, 850105629$domain:VWFA 10, 850105630$domain:VWFA 11, 850105631$domain:VWFA 12, 850105633$domain:VWFA 2, 850105634$domain:VWFA 3, 850105637$domain:VWFA 4, 850105638$domain:VWFA 5, 850105639$domain:VWFA 6, 850105640$domain:VWFA 7, 850105641$domain:VWFA 8, 850105642$domain:VWFA 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850105818$glycosylation site:O-linked (Gal...), 850105852$helix, 850106258$modified residue, 850113761$region of interest:Nonhelical region, 850114937$region of interest:Triple-helical region, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116314$repeat:LRR 15, 850116315$repeat:LRR 16, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide, 850118488$site:Reactive bond, 850118574$splice variant, 850118575$strand, 850118624$turn]
cytoplasmic polyadenylation element binding protein 3,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
cytoplasmic polyadenylation element binding protein 3,SMART[760000328$SM00360:RRM]
cytoplasmic polyadenylation element binding protein 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
cytoplasmic polyadenylation element binding protein 3,UP_SEQ_FEATURE[850014052$chain:Cytoplasmic polyadenylation element- binding protein 3, 850102378$compositionally biased region:Ala-rich, 850102485$compositionally biased region:Gln-rich, 850102586$compositionally biased region:Pro-rich, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
dysbindin (dystrobrevin binding protein 1) domain containing 1,INTERPRO[450006885$IPR007531:Dysbindin]
dysbindin (dystrobrevin binding protein 1) domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
dysbindin (dystrobrevin binding protein 1) domain containing 1,UP_SEQ_FEATURE[850016553$chain:Dysbindin domain-containing protein 1, 850117294$sequence conflict, 850118574$splice variant]
exocyst complex component 6,INTERPRO[450006595$IPR007225:Exocyst complex subunit Sec15-like]
exocyst complex component 6,PIR_SUPERFAMILY[630019487$PIRSF025007:exocyst complex, component Sec15, 630019488$PIRSF025007:Sec15]
exocyst complex component 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000522$exocytosis, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
exocyst complex component 6,UP_SEQ_FEATURE[850018194$chain:Exocyst complex component 6, 850117294$sequence conflict, 850117295$sequence variant]
kelch-like 31 (Drosophila),INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010360$IPR011498:Kelch repeat type 2, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller, 450015416$IPR017096:Kelch-like protein, gigaxonin]
kelch-like 31 (Drosophila),PIR_SUPERFAMILY[630028539$PIRSF037037:Kelch-like_protein_gigaxonin]
kelch-like 31 (Drosophila),SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
kelch-like 31 (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000819$kelch repeat, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
kelch-like 31 (Drosophila),UP_SEQ_FEATURE[850027145$chain:Kelch-like protein 31, 850103083$domain:BACK, 850103177$domain:BTB, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850116254$repeat:Kelch 6, 850117295$sequence variant]
leucine rich repeat transmembrane neuronal 2,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
leucine rich repeat transmembrane neuronal 2,SMART[760000007$SM00013:LRRNT, 760000333$SM00369:LRR_TYP]
leucine rich repeat transmembrane neuronal 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790000919$membrane, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
leucine rich repeat transmembrane neuronal 2,UP_SEQ_FEATURE[850028352$chain:Leucine-rich repeat transmembrane neuronal protein 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
lipase, endothelial,INTERPRO[450000631$IPR000734:Lipase, 450000897$IPR001024:Lipoxygenase, LH2, 450002073$IPR002330:Lipoprotein lipase, 450012422$IPR013818:Lipase, N-terminal, 450014596$IPR016272:Lipoprotein lipase, LIPH]
lipase, endothelial,KEGG_PATHWAY[470038775$hsa00561:Glycerolipid metabolism]
lipase, endothelial,OMIM_DISEASE[520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520002930$Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts, 520003638$Newly identified loci that influence lipid concentrations and risk of coronary artery disease, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
lipase, endothelial,PIR_SUPERFAMILY[630001000$PIRSF000865:lipoprotein lipase, LIPH type, 630001001$PIRSF000865:Lipoprotein_lipase_LIPH]
lipase, endothelial,SMART[760000278$SM00308:LH2]
lipase, endothelial,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000669$heparin-binding, 790000743$hydrolase, 790000869$lipid degradation, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
lipase, endothelial,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850000090$active site:Nucleophile, 850017430$chain:Endothelial lipase, 850102585$compositionally biased region:Poly-Val, 850102883$disulfide bond, 850105029$domain:PLAT, 850105770$glycosylation site:N-linked (GlcNAc...), 850111863$region of interest:Heparin-binding, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B,INTERPRO[450006166$IPR006759:Glycosyl transferase, family 54]
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B,KEGG_PATHWAY[470038766$hsa00510:N-Glycan biosynthesis]
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000919$membrane, 790000937$metal-binding, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B,UP_SEQ_FEATURE[850004606$chain:Alpha-1,3-mannosyl-glycoprotein 4-beta-N- acetylglucosaminyltransferase B, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
olfactory receptor, family 1, subfamily F, member 2,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 1, subfamily F, member 2,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 1, subfamily F, member 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000919$membrane, 790001069$olfaction, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 1, subfamily F, member 2,UP_SEQ_FEATURE[850035628$chain:Olfactory receptor 1F2, 850102883$disulfide bond, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
outer dense fiber of sperm tails 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001212$polymorphism, 790001304$repeat, 790001426$spermatogenesis]
outer dense fiber of sperm tails 1,UP_SEQ_FEATURE[850036329$chain:Outer dense fiber protein 1, 850110044$region of interest:2 X 5 AA repeats of [RC]-C-L-C-D, 850111144$region of interest:C-X-P repeat region, 850115074$repeat:1, 850115273$repeat:2, 850117294$sequence conflict, 850117295$sequence variant]
polymerase (RNA) I polypeptide B, 128kDa,COG_ONTOLOGY[90000115$Transcription]
polymerase (RNA) I polypeptide B, 128kDa,INTERPRO[450006494$IPR007120:DNA-directed RNA polymerase, subunit 2, domain 6, 450006495$IPR007121:RNA polymerase, beta subunit, conserved site, 450006999$IPR007641:RNA polymerase Rpb2, domain 7, 450007000$IPR007642:RNA polymerase Rpb2, domain 2, 450007001$IPR007644:RNA polymerase, beta subunit, protrusion, 450007002$IPR007645:RNA polymerase Rpb2, domain 3, 450007004$IPR007647:RNA polymerase Rpb2, domain 5, 450008767$IPR009674:RNA polymerase I, Rpa2 specific, 450014147$IPR015712:DNA-directed RNA polymerase, subunit 2]
polymerase (RNA) I polypeptide B, 128kDa,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism, 470038744$hsa00240:Pyrimidine metabolism, 470038815$hsa03020:RNA polymerase]
polymerase (RNA) I polypeptide B, 128kDa,PIR_SUPERFAMILY[630000885$PIRSF000765:DNA-directed RNA polymerase 132K polypeptide]
polymerase (RNA) I polypeptide B, 128kDa,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000468$dna-directed rna polymerase, 790000937$metal-binding, 790001064$nucleotidyltransferase, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
polymerase (RNA) I polypeptide B, 128kDa,UP_SEQ_FEATURE[850016040$chain:DNA-directed RNA polymerase I subunit RPA2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118762$zinc finger region:C4-type]
proline rich 14,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
proline rich 14,UP_SEQ_FEATURE[850044601$chain:Proline-rich protein 14, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117295$sequence variant]
proteasome (prosome, macropain) subunit, alpha type, 1,BIOCARTA[30000204$h_no1Pathway:Actions of Nitric Oxide in the Heart]
proteasome (prosome, macropain) subunit, alpha type, 1,INTERPRO[450000365$IPR000426:Proteasome, alpha-subunit, conserved site, 450001196$IPR001353:Proteasome, alpha and beta subunits, 450001197$IPR001353:Proteasome, subunit alpha/beta]
proteasome (prosome, macropain) subunit, alpha type, 1,KEGG_PATHWAY[470038819$hsa03050:Proteasome]
proteasome (prosome, macropain) subunit, alpha type, 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000763$immune response, 790000811$isopeptide bond, 790001065$nucleus, 790001162$phosphoprotein, 790001252$Protease, 790001254$proteasome, 790001516$threonine protease, 790001592$ubl conjugation]
proteasome (prosome, macropain) subunit, alpha type, 1,UP_SEQ_FEATURE[850044854$chain:Proteasome subunit alpha type-1, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
retinitis pigmentosa GTPase regulator interacting protein 1,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting]
retinitis pigmentosa GTPase regulator interacting protein 1,OMIM_DISEASE[520001153$Cone-rod dystrophy 13, 520002785$Leber congenital amaurosis 6, 520002791$Leber congenital amaurosis VI]
retinitis pigmentosa GTPase regulator interacting protein 1,SMART[760000211$SM00239:C2]
retinitis pigmentosa GTPase regulator interacting protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000267$cell projection, 790000321$cilium, 790000344$coiled coil, 790000356$complete proteome, 790000357$Cone-rod dystrophy, 790000446$disease mutation, 790000846$leber congenital amaurosis, 790001212$polymorphism, 790001377$sensory transduction, 790001622$vision]
retinitis pigmentosa GTPase regulator interacting protein 1,UP_SEQ_FEATURE[850100982$chain:X-linked retinitis pigmentosa GTPase regulator-interacting protein 1, 850103199$domain:C2, 850112792$region of interest:Interaction with RPGR, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ribosomal protein S25 pseudogene 8; ribosomal protein S25,INTERPRO[450004446$IPR004977:Ribosomal protein S25]
ribosomal protein S25 pseudogene 8; ribosomal protein S25,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein S25 pseudogene 8; ribosomal protein S25,PIR_SUPERFAMILY[630002279$PIRSF002150:ribosomal protein S25]
ribosomal protein S25 pseudogene 8; ribosomal protein S25,SP_PIR_KEYWORDS[790000012$acetylation, 790000189$blocked amino end, 790000356$complete proteome, 790000445$direct protein sequencing, 790001255$protein biosynthesis, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome]
ribosomal protein S25 pseudogene 8; ribosomal protein S25,UP_SEQ_FEATURE[850002013$chain:40S ribosomal protein S25, 850106258$modified residue]
ring finger protein 8,INTERPRO[450000219$IPR000253:Forkhead-associated, 450001628$IPR001841:Zinc finger, RING-type, 450015659$IPR017335:E3 ubiquitin ligase, RNF8, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
ring finger protein 8,PIR_SUPERFAMILY[630029522$PIRSF037950:E3 ubiquitin-protein ligase RNF8, 630029523$PIRSF037950:E3_ubiquit_lig_RNF8]
ring finger protein 8,SMART[760000158$SM00184:RING, 760000212$SM00240:FHA]
ring finger protein 8,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000311$chromatin regulator, 790000315$chromosomal protein, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000859$ligase, 790000937$metal-binding, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
ring finger protein 8,UP_SEQ_FEATURE[850016728$chain:E3 ubiquitin-protein ligase RNF8, 850102485$compositionally biased region:Gln-rich, 850103775$domain:FHA, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118911$zinc finger region:RING-type]
similar to AAA-ATPase  TOB3; ATPase family, AAA domain containing 3B,COG_ONTOLOGY[90000108$Secondary metabolites biosynthesis, transport, and catabolism / Transcription]
similar to AAA-ATPase  TOB3; ATPase family, AAA domain containing 3B,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core]
similar to AAA-ATPase  TOB3; ATPase family, AAA domain containing 3B,SMART[760000335$SM00382:AAA]
similar to AAA-ATPase  TOB3; ATPase family, AAA domain containing 3B,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790001063$nucleotide-binding, 790001212$polymorphism]
similar to AAA-ATPase  TOB3; ATPase family, AAA domain containing 3B,UP_SEQ_FEATURE[850006788$chain:ATPase family AAA domain-containing protein 3B, 850102580$compositionally biased region:Poly-Pro, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1,BIOCARTA[30000178$h_malatexPathway:Shuttle for transfer of acetyl groups from mitochondria to the cytosol]
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001830$IPR002067:Mitochondrial carrier protein, 450001872$IPR002113:Adenine nucleotide translocator 1, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001304$repeat, 790001550$transit peptide, 790001555$transmembrane, 790001558$transport]
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1,UP_SEQ_FEATURE[850066548$chain:Tricarboxylate transport protein, mitochondrial, 850106258$modified residue, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117294$sequence conflict, 850118617$transit peptide:Mitochondrion, 850118623$transmembrane region]
solute carrier family 31 (copper transporters), member 1,INTERPRO[450006641$IPR007274:Ctr copper transporter]
solute carrier family 31 (copper transporters), member 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000371$copper, 790000373$copper transport, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
solute carrier family 31 (copper transporters), member 1,UP_SEQ_FEATURE[850023674$chain:High affinity copper uptake protein 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
sorting nexin family member 30,COG_ONTOLOGY[90000081$Intracellular trafficking and secretion / General function prediction only]
sorting nexin family member 30,INTERPRO[450001492$IPR001683:Phox-like]
sorting nexin family member 30,SMART[760000282$SM00312:PX]
sorting nexin family member 30,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
sorting nexin family member 30,UP_SEQ_FEATURE[850061556$chain:Sorting nexin-30, 850105129$domain:PX, 850106258$modified residue, 850117295$sequence variant]
synaptotagmin VI,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450001391$IPR001565:Synaptotagmin, 450016334$IPR018029:C2 membrane targeting protein]
synaptotagmin VI,PIR_SUPERFAMILY[630002502$PIRSF002385:B/K protein/synaptotagmin]
synaptotagmin VI,SMART[760000211$SM00239:C2]
synaptotagmin VI,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000263$cell junction, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000919$membrane, 790000937$metal-binding, 790001304$repeat, 790001475$synapse, 790001555$transmembrane]
synaptotagmin VI,UP_SEQ_FEATURE[850063215$chain:Synaptotagmin-6, 850103200$domain:C2 1, 850103201$domain:C2 2, 850105910$metal ion-binding site:Calcium 1, 850105915$metal ion-binding site:Calcium 1; via carbonyl oxygen, 850105918$metal ion-binding site:Calcium 2, 850105925$metal ion-binding site:Calcium 3, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118606$topological domain:Vesicular, 850118623$transmembrane region]
tandem C2 domains, nuclear,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450016334$IPR018029:C2 membrane targeting protein]
tandem C2 domains, nuclear,SMART[760000211$SM00239:C2]
tandem C2 domains, nuclear,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
tandem C2 domains, nuclear,UP_SEQ_FEATURE[850063516$chain:Tandem C2 domains nuclear protein, 850103199$domain:C2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
transcription factor 25 (basic helix-loop-helix),INTERPRO[450006390$IPR006994:Basic helix-loop-helix, Nulp1-type]
transcription factor 25 (basic helix-loop-helix),SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
transcription factor 25 (basic helix-loop-helix),UP_SEQ_FEATURE[850064986$chain:Transcription factor 25, 850106258$modified residue]
transferrin receptor 2,INTERPRO[450002761$IPR003137:Protease-associated PA, 450006727$IPR007365:Transferrin receptor-like, dimerisation, 450006838$IPR007484:Peptidase M28]
transferrin receptor 2,OMIM_DISEASE[520002253$Hemochromatosis, type 3]
transferrin receptor 2,PIR_SUPERFAMILY[630002664$PIRSF002548:transferrin receptor]
transferrin receptor 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane]
transferrin receptor 2,UP_SEQ_FEATURE[850065735$chain:Transferrin receptor protein 2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117444$short sequence motif:Endocytosis signal, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
transmembrane protein 57,INTERPRO[450017376$IPR019130:Transmembrane protein Macoilin]
transmembrane protein 57,OMIM_DISEASE[520002930$Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts]
transmembrane protein 57,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane]
transmembrane protein 57,UP_SEQ_FEATURE[850029465$chain:Macoilin, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
v-raf murine sarcoma viral oncogene homolog B1,BIOCARTA[30000180$h_mapkPathway:MAPKinase Signaling Pathway]
v-raf murine sarcoma viral oncogene homolog B1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001967$IPR002219:Protein kinase C, phorbol ester/diacylglycerol binding, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding, 450002740$IPR003116:Raf-like Ras-binding, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
v-raf murine sarcoma viral oncogene homolog B1,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038828$hsa04012:ErbB signaling pathway, 470038831$hsa04062:Chemokine signaling pathway, 470038842$hsa04150:mTOR signaling pathway, 470038845$hsa04270:Vascular smooth muscle contraction, 470038853$hsa04510:Focal adhesion, 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway, 470038878$hsa04730:Long-term depression, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038882$hsa04910:Insulin signaling pathway, 470038884$hsa04914:Progesterone-mediated oocyte maturation, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038901$hsa05211:Renal cell carcinoma, 470038902$hsa05212:Pancreatic cancer, 470038903$hsa05213:Endometrial cancer, 470038904$hsa05214:Glioma, 470038905$hsa05215:Prostate cancer, 470038906$hsa05216:Thyroid cancer, 470038908$hsa05218:Melanoma, 470038909$hsa05219:Bladder cancer, 470038910$hsa05220:Chronic myeloid leukemia, 470038911$hsa05221:Acute myeloid leukemia, 470038913$hsa05223:Non-small cell lung cancer]
v-raf murine sarcoma viral oncogene homolog B1,OMIM_DISEASE[520000125$Adenocarcinoma of lung, somatic, 520000761$Cardiofaciocutaneous syndrome, 520001101$Colorectal cancer, somatic, 520003132$Melanoma, melignant, somatic, 520003677$Nonsmall cell lung cancer, somatic]
v-raf murine sarcoma viral oncogene homolog B1,PIR_SUPERFAMILY[630000663$PIRSF000555:serine/threonine-protein kinase, A/B-Raf proto-oncogene types]
v-raf murine sarcoma viral oncogene homolog B1,SMART[760000096$SM00109:C1, 760000400$SM00455:RBD]
v-raf murine sarcoma viral oncogene homolog B1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000134$ATP, 790000138$atp-binding, 790000149$autophosphorylation, 790000245$Cardiomyopathy, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000825$kinase, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001271$Proto-oncogene, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001407$signal transduction, 790001547$transferase, 790001549$transforming protein, 790001648$zinc, 790001651$zinc-finger]
v-raf murine sarcoma viral oncogene homolog B1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850007069$chain:B-Raf proto-oncogene serine/threonine- protein kinase, 850102573$compositionally biased region:Poly-Gly, 850102581$compositionally biased region:Poly-Ser, 850105086$domain:Protein kinase, 850105150$domain:RBD, 850105852$helix, 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn, 850118892$zinc finger region:Phorbol-ester/DAG-type]
zinc finger CCCH-type containing 10,INTERPRO[450000486$IPR000571:Zinc finger, CCCH-type]
zinc finger CCCH-type containing 10,SMART[760000324$SM00356:ZnF_C3H1]
zinc finger CCCH-type containing 10,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
zinc finger CCCH-type containing 10,UP_SEQ_FEATURE[850101297$chain:Zinc finger CCCH domain-containing protein 10, 850102517$compositionally biased region:Gly-rich, 850102573$compositionally biased region:Poly-Gly, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850118752$zinc finger region:C3H1-type 1, 850118753$zinc finger region:C3H1-type 2, 850118754$zinc finger region:C3H1-type 3]
zinc finger CCCH-type containing 7A,INTERPRO[450000486$IPR000571:Zinc finger, CCCH-type, 450006475$IPR007087:Zinc finger, C2H2-type, 450010815$IPR011990:Tetratricopeptide-like helical, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger CCCH-type containing 7A,SMART[760000323$SM00355:ZnF_C2H2, 760000324$SM00356:ZnF_C3H1]
zinc finger CCCH-type containing 7A,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat, 790001648$zinc, 790001651$zinc-finger]
zinc finger CCCH-type containing 7A,UP_SEQ_FEATURE[850101363$chain:Zinc finger CCCH domain-containing protein 7A, 850105852$helix, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118655$zinc finger region:C2H2-type, 850118752$zinc finger region:C3H1-type 1, 850118753$zinc finger region:C3H1-type 2, 850118754$zinc finger region:C3H1-type 3]
zinc finger protein 569,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 569,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 569,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 569,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 569,UP_SEQ_FEATURE[850101749$chain:Zinc finger protein 569, 850104552$domain:KRAB, 850117294$sequence conflict, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118666$zinc finger region:C2H2-type 13, 850118669$zinc finger region:C2H2-type 14, 850118671$zinc finger region:C2H2-type 15, 850118674$zinc finger region:C2H2-type 16, 850118676$zinc finger region:C2H2-type 17, 850118679$zinc finger region:C2H2-type 18, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
